Vita Life Sciences LimitedVita Life Sciences LimitedVita Life Sciences Limited

Vita Life Sciences Limited

No trades

Documents


Explore the latest documents from the company, including regulatory filings and corporate disclosures that offer insight into company performance and strategy. Use these resources to support informed investment decisions.
2025
Earnings, H2 FY2025
Annual
Mar 26, 2026
Record revenue and profit growth, higher dividends, and strong Asia-Pacific momentum.
Earnings, H1 FY2025
Aug 24, 2025
Revenue up 15% and profit before tax up 13% year-over-year, driven by broad-based growth.
AGM 2025
May 22, 2025
Record revenue, increased dividend, and strategic Asian expansion highlighted; all resolutions passed.
2024
Earnings, H2 FY2024
Annual
Feb 22, 2025
Record revenue and higher dividend, but net profit declined amid increased investment.
Earnings, H1 FY2024
Aug 25, 2024
Revenue up 15% and profit before tax up 9%, with strong cash and higher dividend.
2023
Earnings, H2 FY2023
Annual
Mar 18, 2024
Earnings, H1 FY2023
Aug 23, 2023
2022
Earnings, H2 FY2022
Annual
Mar 27, 2023
Earnings, H1 FY2022
Oct 26, 2022
2021
Earnings, H2 FY2021
Annual
Mar 23, 2022
Earnings, H1 FY2021
Aug 20, 2021
2020
Earnings, H2 FY2020
Annual
Mar 24, 2021
2019
Earnings, H2 FY2019
Annual
Mar 25, 2020
2018
Earnings, H2 FY2018
Annual
Mar 26, 2019
2017
Earnings, H2 FY2017
Annual
Mar 21, 2018
2016
Earnings, H2 FY2016
Annual
Mar 28, 2017
2015
Earnings, H2 FY2015
Annual
Mar 30, 2016
2014
Earnings, H2 FY2014
Annual
Mar 26, 2015
2013
Earnings, H2 FY2013
Annual
Mar 31, 2014
2012
Earnings, H2 FY2012
Annual
Mar 26, 2013
2011
Earnings, H2 FY2011
Annual
Mar 23, 2012
2010
Earnings, H2 FY2010
Annual
Mar 24, 2011
2009
Earnings, H2 FY2009
Annual
Mar 29, 2010
2008
Earnings, H2 FY2008
Annual
Mar 19, 2009